NOX4 and Alzheimer disease: In the AD + TMQ group, the immunoreactivity levels of the antibodies examined decreased statistically significantly in comparison to the AD group (Aβ: F (4, 25) = 461.9, p < 0.0001; RAGE: F (4, 25) = 1096, p < 0.0001; NOX4: F (4, 25) = 432.3, p < 0.0001)) (Figure 5B).